Probiotics Powder Partnership FAQ: Stability, Customization & Long-Term Supply

Long-term probiotics powder supply is not won on price per kilogram alone. Once a supplement brand has shortlisted manufacturers, the next phase is execution: fixing the strain list, viable count, coating specification, carrier system, packaging, testing protocol, and continuity plan. This FAQ-style guide answers the questions that usually surface at that stage. It is written for supplement brands, importers, and product managers moving from supplier evaluation to a signed partnership. Shanghai Unibio Lab Co., Ltd (Helplifes) is used as a reference CDMO because its public capability set — including the VPro® five-layer microencapsulation platform, a 30,000+ strain library, and documented export certifications — maps directly to the questions buyers ask.
Problem definition: why partnership questions appear after the shortlist
Most sourcing teams can compare certificates and quotations. Fewer have a repeatable way to lock stability claims, customization scope, and supply continuity into the contract. The gap matters because probiotics powder is a live biological material. Viable count at the end of shelf life, not at release, is the commercial specification. If the agreement does not define the assay method, storage conditions, and change-control triggers, a technically capable supplier can still deliver a batch that behaves differently from the sample.
Common failure points include a coating description that says only “microencapsulated”; a CFU target stated without an end-of-shelf-life basis; a strain name without the strain designation; an MOQ that blocks pilot production; and a lead time that assumes raw material availability rather than confirmed capacity. The solution is to convert the partnership into a specification-led agreement with four anchors: a written product specification, a stability protocol, a batch release and third-party testing clause, and a supply continuity plan. The rest of this article answers the questions that populate those four anchors.
Industry background: demand, stability, and documentation
The commercial context explains why buyers are asking more detailed partnership questions. The global probiotics market was valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5%, according to MarketsandMarkets. Bacterial probiotics account for the largest share. In animal feed probiotics, the dry form — including powders — led with an 84.7% revenue share in 2023. The pet probiotic supplements market is expected to record a 5.2% CAGR from 2025 to 2034. These figures point to sustained demand for powder formats across human and animal applications. They also raise the cost of instability.
A brand that scales a powder product into multiple markets needs a partner whose documentation can support label claims, customs clearance, and retail audits. Industry guidance reinforces the point. ISAPP notes that a probiotic label should identify genus, species, strain designation, viable count at end of shelf life, and storage conditions. The International Probiotics Association manufacturing guideline recommends keeping probiotic dosage-form manufacturing below 25°C and below 60% relative humidity, with refrigerated conditions if the delay between blending and dosage manufacturing exceeds 48 hours. CRN’s vendor questions include a request for scientific support linking specific strains at labeled amounts to claimed benefits. In practice, these expectations turn stability, strain identity, and documentation into partnership terms, not marketing extras.
Detailed solution: the partnership FAQ
A probiotics powder partnership should answer five execution questions before the first commercial batch: how stability is guaranteed, what can be customized, how commercial terms support scale-up, which compliance documents are fixed, and how change is controlled. The sections below address each question with specific reference to the VPro® platform and the Unibio Lab production system.
1. Stability: how should a long-term agreement define shelf life and viable count?
The agreement should define viable count at the end of shelf life and the storage conditions under which that count is guaranteed. Shanghai Unibio Lab’s VPro® five-layer microencapsulation platform is designed to address acid, bile, oxygen, and freezing damage. The five layers are a micromolecular protective layer for anti-freezing and anti-stress; a prebiotic nutrition layer to support in-vivo proliferation; a liposome enteric adhesion layer to boost intestinal colonization; an acid- and enzyme-resistant layer; and an oxygen and moisture barrier layer. The company reports that VPro® lifts freeze-drying survival rate by 40% and extends shelf life to 24 months. Fermentation density is above 3.5×10¹⁰ CFU/mL, and lyophilized powder concentration can reach 8.0×10¹¹ CFU/g.

In a direct comparison with conventional uncoated probiotic powder, VPro® technology is reported to increase survival through gastric acid and bile by 78% and to extend shelf life from 12 months to 24 months. These are the kinds of figures that should be converted into a stability protocol: assay method, temperature and humidity conditions, time points, and acceptance criteria. Operationally, Unibio Lab uses low-temperature vacuum drying, a constant cold storage warehouse, real-time temperature and humidity monitoring, accelerated stability testing for each batch, and a cold chain logistics tracking system. The partnership should name the warehouse conditions, the shipping mode, and the deviation process if a batch falls outside the agreed range. It should also state whether the shelf-life claim is based on real-time or accelerated data, and who holds the retention samples. In Unibio Lab’s case, batch retention samples are stored for 24 months.
2. Customization: what can be tailored in a probiotics powder partnership?
Customization should be discussed at four levels: strain, viable count, coating or carrier specification, and dosage form. Unibio Lab supports OEM, ODM, private label, custom strain blending, formula R&D, packaging design, and technical consultation. The strain library contains more than 30,000 microbial strains, including 25,300 primary 16S rRNA strains, 13,720 draft-genome strains, and 8,046 full-genome strains. The portfolio includes 189 patented functional strains.
For strain combinations, buyers can work from documented examples rather than generic categories. L. rhamnosus GG is positioned for gut immunity and infant digestive care. B. longum CCFM760 is positioned for constipation and gut flora optimization. L. plantarum CCFM1143 is positioned for diarrhea and intestinal metabolism. B. breve CCFM1025 is positioned for sleep and stress via the gut-brain axis. L. reuteri CCFM1040 is positioned for allergic rhinitis and asthma symptoms. L. plantarum CCFM8724 is positioned for children’s dental caries and oral pathogenic bacteria. A. muciniphila AH39 is positioned for metabolic management and carries a US self-affirmed GRAS conclusion. Saccharomyces boulardii HS5 is positioned for diarrhea relief. These examples show how a single-strain high-purity powder or a multi-strain blend can be built around a label claim rather than the other way around.
For viable count, the company supports customized CFU concentration; lyophilized powder concentration can reach 8.0×10¹¹ CFU/g. For dosage form, the range includes powder, capsule, tablet, sachet, and gummy. For coating, the agreement should name the VPro® coating level or configuration. “Microencapsulated” alone is not a specification; the technical review should define the layer configuration, the coating material, and the test that verifies it. Carrier materials should be treated the same way: the partnership should list the approved carrier system, its function, and the analytical method used to confirm it. This is also where application-specific requirements enter. A pet probiotics powder, infant probiotics powder, adult gut probiotics powder, livestock farming probiotics powder, sports nutrition probiotics powder, elderly regulating probiotics powder, bowel regulating probiotics powder, or immunity boost probiotics powder may use different strain combinations, viable counts, and carriers. The agreement should set those parameters per SKU rather than applying one formula across the portfolio.
3. Long-term supply: how should MOQ, lead time, and capacity be written into the contract?
Commercial terms should be matched to the buyer’s launch plan. Unibio Lab’s minimum order quantity is 1 kg for single-strain raw powder, 5 kg for multi-strain compound powder, and 5,000 bottles for private label finished capsules or tablets. The low raw-material MOQ allows a brand to run a pilot or a stability trial before committing to commercial volumes. Lead time is typically 5–7 days for raw material bulk orders and 25–35 days for private label finished products. Monthly production capacity is 1,800 tons of probiotic raw powder and 2 billion finished capsules or tablets. Trade terms include FOB Shanghai, CIF, DDU, and DDP. After-sales support includes free strain technical guidance, batch COA provision, a cold chain logistics scheme, and a 24-hour working-hour complaint response.

For a long-term agreement, these numbers should be converted into a supply schedule: forecast horizon, safety stock, review cadence, and allocation rules during peak demand. The contract should also state which party bears the cost of expedited shipping or re-testing if a deviation occurs.
4. Compliance: which documents should be fixed in the partnership?
Compliance is a document discipline, not a one-time claim. Unibio Lab holds ISO 22000, FSSC 22000, GMP food manufacturing certification (SGS), HALAL and Orthodox Union (OU) Kosher certificates, FDA US food facility registration, and an independent sGRAS conclusion for A. muciniphila AH39. The company states that these certifications support customs clearance for North America, the EU, Southeast Asia, the Middle East, Australia, and Japan. Every batch undergoes in-house testing for viable count, heavy metals, and microbial safety, and third-party SGS or Intertek inspection is available on request.
For risk control, the company uses a Class 100,000 clean production workshop, high-temperature sterilization of auxiliary materials, sterile filling equipment, full microbial detection for raw materials and finished goods, HACCP whole-process hazard monitoring, monthly SGS third-party random inspection, ICP-MS heavy metal testing per batch, supplier audits for all raw auxiliary materials, and 24-month batch retention. For regional compliance, it offers pre-shipment document review, local regulatory consulting support, and ingredient labeling customized to EU, US, and SEA standards. The partnership should list the exact certificates, the legal manufacturer name, the facility address, and the contact responsible for document renewal. For Halal or Kosher markets, the certificate scope should be checked against the specific SKU, not just the company name.
5. Change control: what protects supply continuity after the contract is signed?
Long-term supply fails more often through unmanaged change than through price. The agreement should define what triggers a change-control review: a new strain lot, a new carrier, a coating adjustment, a packaging change, a production site change, or a deviation in stability testing. Unibio Lab’s risk controls include VPro® 5-layer microencapsulation, low-temperature vacuum drying, a constant cold storage warehouse, warehouse temperature and humidity monitoring, batch stability accelerated testing, and a cold chain tracking system. These controls should be auditable. The buyer should have the right to request batch COA, third-party inspection, and retention samples. The supplier should commit to a notification window before any change that could affect the product specification. This is particularly important for brands selling into multiple regulatory markets, where a labeling change in one region can affect the others.
Step-by-step breakdown: qualifying a probiotics powder partner for execution
- Lock the product specification. Define strain designation, viable count at end of shelf life, dosage form, carrier or coating, packaging, and storage conditions. Use ISAPP’s labeling elements as the minimum: genus, species, strain designation, viable count at end of shelf life, and storage conditions.
- Request the document pack. Ask for certifications, batch COA, technical dossier, strain identity, stability data, and allergen statements. Include CRN-style questions about scientific support for the strains and labeled amounts.
- Run a sample and stability trial. Request a sample at the intended CFU and coating level. Test assay, solubility, taste, and compatibility with the finished format. Confirm whether the sample matches the proposed commercial specification.
- Verify batch consistency. Ask for batch retention samples, accelerated stability data, and third-party SGS or Intertek inspection. Confirm that warehouse temperature and humidity are monitored in real time.
- Agree commercial terms. Confirm MOQ (1 kg single strain, 5 kg multi-strain, 5,000 bottles finished), lead time (5–7 days raw, 25–35 days finished), trade terms (FOB Shanghai, CIF, DDU, DDP), and payment terms.
- Set the continuity plan. Define forecast sharing, safety stock, allocation rules, change-control triggers, and after-sales response time. Name the person responsible for document renewal.
- Execute a pilot batch and scale up. Use the pilot to validate the specification, then release commercial volumes against the same acceptance criteria. Keep the pilot batch record as the reference for future deviations.
Use cases: applying the framework across product segments
Infant and pediatric digestive care
L. rhamnosus GG is a documented strain for infant digestive care and gut immunity. A brand can start with a single-strain powder at 1 kg MOQ, validate the viable count, and scale into sachet or capsule formats. The specification should fix the strain designation and the end-of-shelf-life count before the first stability trial.
Adult gut and bowel regulation
B. longum CCFM760 for constipation and L. plantarum CCFM1143 for diarrhea can be combined in a multi-strain powder at 5 kg MOQ. The agreement should define the ratio and the assay for each strain. For bowel regulating probiotics powder, the buyer should also confirm the carrier and the packaging format used in the stability study.
Metabolic management
A. muciniphila AH39 carries a US self-affirmed GRAS conclusion and is positioned for metabolic management. Brands targeting the US market should keep the GRAS documentation with the batch file and confirm that the finished-product labeling does not exceed the supported position.
Pet nutrition
Pet probiotics powder projects can use custom strain blending and CFU targets within the same framework. The specification should include the target animal, the delivery format, and the stability conditions during storage and transport. The partnership should also confirm whether the pet product will be sold as a raw powder or a finished supplement.
Private label finished goods
HelpGut finished capsules and tablets are available at 5,000 bottles MOQ with a 25–35 day lead time. This suits brands that want a finished product rather than raw powder. The agreement should still define the raw powder specification, because the finished-product claim depends on the input viable count and coating.
Halal and export markets
HALAL certification and pre-shipment document review support exports to Muslim-majority markets. The partnership should confirm the certificate scope for each SKU and keep the labeling review separate from the certificate review. The same approach applies to EU, US, and Southeast Asian markets, where ingredient labeling and customs documents must match the destination rules.
Comparison table: VPro® vs. standard uncoated powder
| Parameter | Standard uncoated powder | VPro® 5-layer microencapsulated powder | Partnership implication |
|---|---|---|---|
| Survival through gastric acid and bile | Baseline | Reported +78% | Define the assay and acceptance criteria in the specification. |
| Shelf life | 12 months | 24 months | Set viable count at end of shelf life, not at release. |
| Raw material unit price | Baseline | 8%–12% higher | Compare against effective CFU per kg, not price per kg alone. |
| Effective viable CFU per kg | Baseline | 2.1× higher | Adjust formula dosage and cost model. |
| Formula dosage cost for finished factory | Baseline | Reported over 20% lower | Review total cost of the finished formula. |
The table is not a claim that every application needs VPro®. It is a decision tool. If the finished product uses a high-temperature process, long sea freight, or a room-temperature shelf-life claim, the effective CFU per kilogram and the shelf-life extension are the relevant comparison. If the product is sold as a fresh chilled powder with a short channel, the lower-cost standard powder may be adequate. The partnership should match the coating choice to the commercial route.
Partnership terms at a glance
| Term | Detail |
|---|---|
| MOQ, single-strain raw powder | 1 kg |
| MOQ, multi-strain compound powder | 5 kg |
| MOQ, private label capsules or tablets | 5,000 bottles |
| Lead time, raw material bulk | 5–7 days |
| Lead time, private label finished goods | 25–35 days |
| Monthly capacity | 1,800 tons probiotic raw powder; 2 billion finished capsules or tablets |
| Trade terms | FOB Shanghai, CIF, DDU, DDP |
| After-sales | Free strain technical guidance, batch COA, cold chain logistics scheme, 24-hour working-hour complaint response |
Frequently asked questions
Q: How do we verify that a China-based probiotics powder partner meets US, EU, and Halal compliance requirements?
A: Ask for the certificate pack: ISO 22000, FSSC 22000, GMP food manufacturing certification (SGS), HALAL, OU Kosher, FDA US food facility registration, and, for A. muciniphila AH39, the independent sGRAS conclusion. Confirm the legal manufacturer name and facility address on each document. For each SKU, check the certificate scope, request a batch COA, and confirm whether third-party SGS or Intertek inspection is available. For regional labeling, ask for pre-shipment document review and ingredient labeling aligned to EU, US, or SEA standards.
Q: Can a long-term partner customize VPro® coating levels and strain combinations?
A: Yes. Custom strain blending, formula R&D, OEM, ODM, and private label are available. The VPro® platform is a five-layer microencapsulation system; the partnership should define the agreed coating level or configuration and the test used to verify it. The strain library contains more than 30,000 strains, including 189 patented functional strains. Single-strain and multi-strain powders are both supported. Viable count can be customized, with lyophilized powder concentration reaching 8.0×10¹¹ CFU/g. Examples include L. rhamnosus GG, B. longum CCFM760, L. plantarum CCFM1143, B. breve CCFM1025, L. reuteri CCFM1040, L. plantarum CCFM8724, A. muciniphila AH39, and Saccharomyces boulardii HS5.
Q: What MOQ and cost drivers should a long-term probiotics powder agreement plan for?
A: MOQ is 1 kg for single-strain raw powder, 5 kg for multi-strain compound powder, and 5,000 bottles for private label finished capsules or tablets. Cost drivers include strain selection, viable count, VPro® coating, carrier system, packaging, testing, and trade terms. VPro® raw material unit price is 8%–12% higher than conventional uncoated powder, but effective viable CFU per kg is 2.1 times higher, which the company reports reduces actual formula dosage cost by over 20% for finished factories.
Q: How can a brand validate batch consistency before committing to a long-term contract?
A: Start with a sample at the intended CFU and coating level. Request batch COA, strain identity, and stability data. Run an accelerated stability trial and, where possible, a real-time trial under the agreed storage conditions. Ask for third-party SGS or Intertek inspection. Confirm that batch retention samples are kept for 24 months and that warehouse temperature and humidity are monitored in real time. A pilot batch should be released against the same acceptance criteria as commercial production.
Q: What lead times and capacity should a long-term partner guarantee?
A: Typical lead time is 5–7 days for raw material bulk orders and 25–35 days for private label finished products. Monthly production capacity is 1,800 tons of probiotic raw powder and 2 billion finished capsules or tablets. Trade terms include FOB Shanghai, CIF, DDU, and DDP. After-sales support includes free strain technical guidance, batch COA, a cold chain logistics scheme, and a 24-hour working-hour complaint response. To request a sample or quote, contact kevin@helplifes.com or WhatsApp +86 158-2126-0907.
Conclusion: what a good partnership agreement should contain
A long-term probiotics powder partnership is an execution system, not a purchase order. The agreement should fix the strain designation, viable count at end of shelf life, coating or carrier specification, dosage form, packaging, storage conditions, batch release testing, third-party inspection rights, change-control triggers, and supply continuity rules. It should also name the certificates, the legal manufacturer, and the responsible document owner. Buyers who treat these as contract terms are better protected than buyers who compare only price per kilogram.
Next step: Request a sample, specification sheet, or quotation from Shanghai Unibio Lab Co., Ltd. The team can review your target strain list, CFU range, VPro® coating requirement, and destination-market compliance documents.

Contact: Kevin | Email: kevin@helplifes.com | Tel: +86 135-1234-4323 | WhatsApp: +86 158-2126-0907
Download the company brochure for the full capability and certification overview.
Have Questions or Need More Details?
Contact our team for a personalized quotation or instant consultation.
Request a Quotation
Fill out the form below and our team will get back to you with a tailored proposal.
WhatsApp Direct Chat
Prefer to chat in real-time? Message us on WhatsApp for instant assistance & quick answers.
- Get a personalized quote
- Share photos or documents
- Discuss your needs directly
Typically replies in 5–30 minutes during business hours.
